- Home
- RVP vs TENX Comparison
RVP vs TENX Comparison
Compare RVP & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVP
- TENX
- Stock Information
- Founded
- RVP 1994
- TENX 1967
- Country
- RVP United States
- TENX United States
- Employees
- RVP 227
- TENX N/A
- Industry
- RVP Medical/Dental Instruments
- TENX Biotechnology: Pharmaceutical Preparations
- Sector
- RVP Health Care
- TENX Health Care
- Exchange
- RVP Nasdaq
- TENX Nasdaq
- Market Cap
- RVP 19.8M
- TENX 21.6M
- IPO Year
- RVP 2001
- TENX N/A
- Fundamental
- Price
- RVP $0.67
- TENX $5.82
- Analyst Decision
- RVP
- TENX Strong Buy
- Analyst Count
- RVP 0
- TENX 3
- Target Price
- RVP N/A
- TENX $16.00
- AVG Volume (30 Days)
- RVP 31.2K
- TENX 44.5K
- Earning Date
- RVP 08-13-2025
- TENX 08-12-2025
- Dividend Yield
- RVP N/A
- TENX N/A
- EPS Growth
- RVP N/A
- TENX N/A
- EPS
- RVP N/A
- TENX N/A
- Revenue
- RVP $33,745,343.00
- TENX N/A
- Revenue This Year
- RVP N/A
- TENX N/A
- Revenue Next Year
- RVP N/A
- TENX N/A
- P/E Ratio
- RVP N/A
- TENX N/A
- Revenue Growth
- RVP N/A
- TENX N/A
- 52 Week Low
- RVP $0.56
- TENX $2.80
- 52 Week High
- RVP $1.21
- TENX $7.89
- Technical
- Relative Strength Index (RSI)
- RVP 45.53
- TENX 53.61
- Support Level
- RVP $0.63
- TENX $5.70
- Resistance Level
- RVP $0.68
- TENX $6.65
- Average True Range (ATR)
- RVP 0.04
- TENX 0.54
- MACD
- RVP 0.00
- TENX 0.01
- Stochastic Oscillator
- RVP 31.56
- TENX 46.81
About RVP Retractable Technologies Inc.
Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession. The company's products are the VanishPoint 0.5mL insulin syringe; 1mL tuberculin, insulin, and allergy antigen syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL, and 10mL syringes; the small diameter tube adapter; the blood collection tube holder; the allergy tray; the IV safety catheter; the Patient Safe syringes; the Patient Safe Luer Cap; the VanishPoint Blood Collection Set; and the EasyPoint needle, as well as a standard 3mL syringe packaged with an EasyPoint needle. The company also sells VanishPoint autodisable syringes in the international market in addition to the Company's other products.
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.